Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2923 (LINC02923) is a non-coding RNA gene located in an intergenic region of the human genome. It does not encode a protein, and its transcript likely plays a role in the regulation of gene expression through RNA-mediated mechanisms. While long intergenic non-coding RNAs as a class participate in diverse processes such as cell-cycle control, cell size, and gene regulation, the specific biological functions, disease relevance, and therapeutic potential of LINC02923 in humans have not been described in the literature. There are no known drugs, clinical associations, or biomarker applications linked to LINC02923 at this time[1][3][5][7].
Not applicable; no drugs known to act on LINC02923
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2923 (LINC02923).